{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["chlorogenic acid", "dipeptidyl peptidase IV", "diprotin A", "molecular dynamics simulations", "phenolic acids", "type-2 diabetes mellitus"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36295839", "DateRevised": {"Year": "2022", "Month": "10", "Day": "30"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "10", "Day": "02"}], "Language": ["eng"], "ELocationID": ["937", "10.3390/metabo12100937"], "Journal": {"ISSN": "2218-1989", "JournalIssue": {"Volume": "12", "Issue": "10", "PubDate": {"Year": "2022", "Month": "Oct", "Day": "02"}}, "Title": "Metabolites", "ISOAbbreviation": "Metabolites"}, "ArticleTitle": "Cheminformatics Identification and Validation of Dipeptidyl Peptidase-IV Modulators from Shikimate Pathway-Derived Phenolic Acids towards Interventive Type-2 Diabetes Therapy.", "Abstract": {"AbstractText": ["Recently, dipeptidyl peptidase-IV (DPP-IV) has become an effective target in the management of type-2 diabetes mellitus (T2D). The study aimed to determine the efficacy of shikimate pathway-derived phenolic acids as potential DPP-IV modulators in the management of T2D. The study explored in silico (molecular docking and dynamics simulations) and in vitro (DPP-IV inhibitory and kinetics assays) approaches. Molecular docking findings revealed chlorogenic acid (CA) among the examined 22 phenolic acids with the highest negative binding energy (-9.0 kcal/mol) showing a greater affinity for DPP-IV relative to the standard, Diprotin A (-6.6 kcal/mol). The result was corroborated by MD simulation where it had a higher affinity (-27.58 kcal/mol) forming a more stable complex with DPP-IV than Diprotin A (-12.68 kcal/mol). These findings were consistent with in vitro investigation where it uncompetitively inhibited DPP-IV having a lower IC<sub>50</sub> (0.3 mg/mL) compared to Diprotin A (0.5 mg/mL). While CA showed promising results as a DPP-IV inhibitor, the findings from the study highlighted the significance of medicinal plants particularly shikimate-derived phenolic compounds as potential alternatives to synthetic drugs in the effective management of T2DM. Further studies, such as derivatisation for enhanced activity and in vivo evaluation are suggested to realize its full potential in T2D therapy."]}, "AuthorList": [{"Identifier": ["0000-0002-1125-0107"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology and Food Science, Faculty of Applied Science, Durban University of Technology, Durban 4001, South Africa."}], "LastName": "Balogun", "ForeName": "Fatai Oladunni", "Initials": "FO"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology and Food Science, Faculty of Applied Science, Durban University of Technology, Durban 4001, South Africa."}], "LastName": "Naidoo", "ForeName": "Kaylene", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology and Food Science, Faculty of Applied Science, Durban University of Technology, Durban 4001, South Africa."}], "LastName": "Aribisala", "ForeName": "Jamiu Olaseni", "Initials": "JO"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology and Food Science, Faculty of Applied Science, Durban University of Technology, Durban 4001, South Africa."}], "LastName": "Pillay", "ForeName": "Charlene", "Initials": "C"}, {"Identifier": ["0000-0001-7209-9220"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology and Food Science, Faculty of Applied Science, Durban University of Technology, Durban 4001, South Africa."}], "LastName": "Sabiu", "ForeName": "Saheed", "Initials": "S"}], "GrantList": [{"GrantID": "120433", "Agency": "National Research Foundation", "Country": ""}, {"GrantID": "NA", "Agency": "Durban University of Technology", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Metabolites", "NlmUniqueID": "101578790", "ISSNLinking": "2218-1989"}, "CoiStatement": "The authors declared no conflicting interest regarding the publication of the article. Submitting author is responsible for co-authors declaring their interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Ali M.Y., Jannat S., Rahman M.M. Investigation of C-glycosylated apigenin and luteolin derivatives\u2019 effects on protein tyrosine phosphatase 1B inhibition with molecular and cellular approaches. Comput. Toxicol. 2020;17:100141. doi: 10.1016/j.comtox.2020.100141.", "ArticleIdList": ["10.1016/j.comtox.2020.100141"]}, {"Citation": "World Health Organization  Diabetes.  [(accessed on 13 December 2021)]; Available online:  https://www.who.int/news-room/fact-sheets/detail/diabetes."}, {"Citation": "Singh A.K., Yadav D., Sharma N., Jin J.-O. Dipeptidyl peptidase (DPP)-IV inhibitors with antioxidant potential isolated from natural sources: A novel approach for the management of diabetes. Pharmaceuticals. 2021;14:586. doi: 10.3390/ph14060586.", "ArticleIdList": ["10.3390/ph14060586", "PMC8234173", "34207217"]}, {"Citation": "Li N., Wang L., Jiang B., Li X., Guo C., Guo S., Shi D. Recent progress of the development of dipeptidyl peptidase-4 inhibitors for the treatment of type-2 diabetes mellitus. Eur. J. Med. Chem. 2018;151:145\u2013157. doi: 10.1016/j.ejmech.2018.03.041.", "ArticleIdList": ["10.1016/j.ejmech.2018.03.041", "29609120"]}, {"Citation": "Chaudhury A., Voor C., Dendi R., Sena V., Kraleti S., Chada A., Ravilla R., Marco A., Shekhawat N.S., Montales M.T., et al. Clinical review of antidiabetic drugs: Implications for type-2 diabetes mellitus management. Front. Endocrinol. 2017;8:6. doi: 10.3389/fendo.2017.00006.", "ArticleIdList": ["10.3389/fendo.2017.00006", "PMC5256065", "28167928"]}, {"Citation": "Singh A.K., Patel P.K., Choudhary K., Joshi J., Yadav D., Jin J.-O. Quercetin and coumarin inhibit dipeptidyl peptidase-IV and exhibits antioxidant properties: In silico, in vitro, ex vivo. Biomolecules. 2020;10:207. doi: 10.3390/biom10020207.", "ArticleIdList": ["10.3390/biom10020207", "PMC7072504", "32023875"]}, {"Citation": "Abbas G., Al-Harrasi A., Hussain H., Hamaed A., Supuran C.T. The management of diabetes mellitus-imperative role of natural products against dipeptidyl peptidase-4, \u03b1-glucosidase and sodium-dependent glucose Co-transporter 2 (SGLT2) Bioorg. Chem. 2019;86:305\u2013315. doi: 10.1016/j.bioorg.2019.02.009.", "ArticleIdList": ["10.1016/j.bioorg.2019.02.009", "30738330"]}, {"Citation": "Dhameja M., Gupta P. Synthetic heterocyclic candidates as promising \u03b1-glucosidase inhibitors: An overview. Eur. J. Med. Chem. 2019;176:343\u2013377. doi: 10.1016/j.ejmech.2019.04.025.", "ArticleIdList": ["10.1016/j.ejmech.2019.04.025", "31112894"]}, {"Citation": "M\u00fcller T., Finan B., Bloom S., D\u2019Alessio D., Drucker D., Flatt P., Fritsche A., Gribble F., Grill H., Habener J., et al. Glucagon-like peptide 1 (glp-1) Mol. Metab. 2019;30:72\u2013130. doi: 10.1016/j.molmet.2019.09.010.", "ArticleIdList": ["10.1016/j.molmet.2019.09.010", "PMC6812410", "31767182"]}, {"Citation": "Gribble F.M., Reimann F. Metabolic messengers: Glucagon-like peptide 1. Nat. Metab. 2021;3:142\u2013148. doi: 10.1038/s42255-020-00327-x.", "ArticleIdList": ["10.1038/s42255-020-00327-x", "33432200"]}, {"Citation": "Iheagwam F.N., Ogunlana O.O., Chinedu S.N. Model optimization and in silico analysis of potential dipeptidyl peptidase IV antagonists from GC-MS identified compounds in Nauclea latifolia leaf extracts. Int. J. Mol. Sci. 2019;20:5913. doi: 10.3390/ijms20235913.", "ArticleIdList": ["10.3390/ijms20235913", "PMC6929178", "31775302"]}, {"Citation": "Gallawitz B. Clinical use of DPP-4 inhibitors. Front. Endocrinol. 2019;10:389. doi: 10.3389/fendo.2019.00389.", "ArticleIdList": ["10.3389/fendo.2019.00389", "PMC6593043", "31275246"]}, {"Citation": "Fan J.F., Johnson M.H., Lila M.A., Yousef G., Mejia E.J. Berry and citrus phenolic compounds inhibit dipeptidyl peptidase IV: Implications in diabetes management. Evid. Based Complement. Altern. Med. 2013;2013:479505. doi: 10.1155/2013/479505.", "ArticleIdList": ["10.1155/2013/479505", "PMC3773436", "24069048"]}, {"Citation": "Kalhotra P., Chittepu V.C.S.R., Osorio-Revilla G., Gallardo-Vel\u00e1zquez T. Structure-activity relationship and molecular docking of natural product library reveal chrysin as a novel dipeptidyl peptidase-4 (DPP-4) inhibitor: An integrated in silico and in vitro study. Molecules. 2018;23:1368. doi: 10.3390/molecules23061368.", "ArticleIdList": ["10.3390/molecules23061368", "PMC6100528", "29882783"]}, {"Citation": "Alexandra Q., Nur K.K., Pei C.L., Dai C.T., Muhammad Alif M.A., Amin I., Khozirah S., Khalijah A. \u03b1-Amylase and dipeptidyl peptidase-4 (DPP-4) inhibitory effects of Melicope latifolia bark extracts and identification of bioactive constituents using in vitro and in silico approaches. Pharm. Biol. 2021;59:962\u2013971. doi: 10.1080/13880209.2021.1948065.", "ArticleIdList": ["10.1080/13880209.2021.1948065", "PMC8344235", "34347568"]}, {"Citation": "Gao Y., Zhang Y., Zhu J., Li B., Li Z., Zhu W., Li Y. Recent progress in natural products as DPP-4 inhibitors. Future Med. Chem. 2015;7:1079\u20131089. doi: 10.4155/fmc.15.49.", "ArticleIdList": ["10.4155/fmc.15.49", "26062402"]}, {"Citation": "Zhang L. Ph.D. Thesis. Jilin University; Jilin, China: 2013. Identification of Isoquercitrin as An Inhibitor Of DPPIV: Implications for Insulin Secretion and Hyperglycemic in Type 2 Diabetes Mice."}, {"Citation": "Sliwoski G., Kothiwale S., Meiler J., Lowe Jr E.W. Computational methods in drug discovery. Pharm. Rev. 2014;66:334\u2013395. doi: 10.1124/pr.112.007336.", "ArticleIdList": ["10.1124/pr.112.007336", "PMC3880464", "24381236"]}, {"Citation": "Ibrahim M.A., Serem J.C., Bester M.J., Neitz A.W., Gaspar A.R. Multiple antidiabetic effects of three a-glucosidase inhibitory peptides, PFP, YPL and YPG: Dipeptidyl peptidase-IV inhibition, suppression of lipid accumulation in differentiated 3T3-L-1 adipocytes and scavenging activity on methylglyoxal. Int. J. Biol. Macromol. 2019;122:104\u2013114. doi: 10.1016/j.ijbiomac.2018.10.152.", "ArticleIdList": ["10.1016/j.ijbiomac.2018.10.152", "30365987"]}, {"Citation": "Kim S., Thiessen P.A., Bolton E.E., Chen J., Fu G., Gindulyte A., Bryant S.H. PubChem substance and compound databases. Nucleic. Acids Res. 2016;44:1202\u20131213. doi: 10.1093/nar/gkv951.", "ArticleIdList": ["10.1093/nar/gkv951", "PMC4702940", "26400175"]}, {"Citation": "Forli S., Huey R., Pique M.E., Sanner M.F., Goodsell D.S., Olson A.J. Computational protein-ligand docking and virtual drug screening with the AutoDock suite. Nat. Protoc. 2016;11:905\u2013919. doi: 10.1038/nprot.2016.051.", "ArticleIdList": ["10.1038/nprot.2016.051", "PMC4868550", "27077332"]}, {"Citation": "Aribisala J.O., Sabiu S. Cheminformatics Identification of Phenolics as Modulators of Penicillin-Binding Protein 2a of Staphylococcus aureus: A Structure-Activity-Relationship-Based Study. Pharmaceutics. 2022;14:1818. doi: 10.3390/pharmaceutics14091818.", "ArticleIdList": ["10.3390/pharmaceutics14091818", "PMC9503099", "36145565"]}, {"Citation": "Sabiu S., Balogun F.O., Amoo S.O. Phenolics profiling of Carpobrotus edulis (L.) N.E.Br. and insights into molecular dynamics of their significance in type-2 diabetes therapy and its retinopathy complication. Molecules. 2021;26:4867. doi: 10.3390/molecules26164867.", "ArticleIdList": ["10.3390/molecules26164867", "PMC8401050", "34443458"]}, {"Citation": "Gonnet P. P-SHAKE: A quadratically convergent SHAKE. J. Comput. Phys. 2007;220:740\u2013750. doi: 10.1016/j.jcp.2006.05.032.", "ArticleIdList": ["10.1016/j.jcp.2006.05.032"]}, {"Citation": "Sabiu S., Idowu K. An insight on the nature of biochemical interactions between glycyrrhizin, myricetin and CYP3A4 isoform. J. Food Biochem. 2022;46:e13831. doi: 10.1111/jfbc.13831.", "ArticleIdList": ["10.1111/jfbc.13831", "34164820"]}, {"Citation": "Daina A., Michielin O., Zoete V. SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 2017;7:42717. doi: 10.1038/srep42717.", "ArticleIdList": ["10.1038/srep42717", "PMC5335600", "28256516"]}, {"Citation": "Oliveira V.B., Araujo R.L., Eidenberger T., Brandao M.G. Chemical composition and inhibitory activities on dipeptidyl peptidase IV and pancreatic lipase of two underutilized species from the Brazilian Savannah: Oxalis cordata A.St-Hil. and Xylopia aromatica (Lam.) Mart. Food Res. Int. 2018;105:989\u2013999. doi: 10.1016/j.foodres.2017.11.079.", "ArticleIdList": ["10.1016/j.foodres.2017.11.079", "29433298"]}, {"Citation": "Jung H., Cho Y., Oh S., Lee S., Min B., Moon K., Choi J. Kinetics and molecular docking studies of pimarane-type diterpenes as protein tyrosine phosphatase (PTP1B) inhibitors from Aralia continentalis roots. Arch. Pharmacal. Res. 2013;36:957\u2013965. doi: 10.1007/s12272-013-0131-5.", "ArticleIdList": ["10.1007/s12272-013-0131-5", "23604820"]}, {"Citation": "Lineweaver H., Burke D. The determination of enzyme dissociation constants. J. Am. Chem. Soc. 1934;56:658\u2013666. doi: 10.1021/ja01318a036.", "ArticleIdList": ["10.1021/ja01318a036"]}, {"Citation": "Seifert E. Origin Pro 9.1: Scientific Data Analysis and Graphing Software-Software Review. J. Chem. Inf. Model. 2014;54:1552. doi: 10.1021/ci500161d.", "ArticleIdList": ["10.1021/ci500161d", "24702057"]}, {"Citation": "Hern\u00e1ndez-Santoyo A., Yair A., Altuzar V., Vivanco-Cid H., Mendoza-Barrer C.  Protein-protein and protein-ligand docking. In: Ogawa T., editor. Protein Engineering\u2014Technology and Application. IntechOpen Publishing; London, UK: 2013.  [(accessed on 10 January 2022)].  Available online:  https://www.intechopen.com/chapters/44790."}, {"Citation": "Lammi C., Bartolomei M., Bollati C., Cecchi L., Bellumori M., Sabato E., Giulio V., Mulinacci A., Arnoldi A. Phenolic extracts from extract virgin olive oils inhibit dipeptidyl peptidase IV activity: In vitro, cellular, and in silico molecular modelling investigations. Antioxidants. 2021;10:1133. doi: 10.3390/antiox10071133.", "ArticleIdList": ["10.3390/antiox10071133", "PMC8301156", "34356366"]}, {"Citation": "Jasmine M., Tunnicliffe L., Eller K., Dustin S.H., Shearer J. Chlorogenic acid differentially affects postprandial glucose and glucose-dependent insulinotropic polypeptide response in rats. Appl Physiol. Nutr. Metab. 2011;36:650\u2013659. doi: 10.1139/h11-072.", "ArticleIdList": ["10.1139/h11-072", "21977912"]}, {"Citation": "Oliveira L., Carvalho M., Melo L. Health promoting and sensory properties of phenolic compounds in food. Rev. Ceres. 2014;61:764\u2013779. doi: 10.1590/0034-737x201461000002.", "ArticleIdList": ["10.1590/0034-737x201461000002"]}, {"Citation": "Vergara R., Romero-Romero S., Vel\u00e1zquez-L\u00f3pez I., Espinoza-P\u00e9rez G., Rodr\u00edguez-Hern\u00e1ndez A., Pulido N.O., Sosa-Peinado A., Rodr\u00edguez-Romero A., Fern\u00e1ndez-Velasco D.A. The interplay of protein-ligand and water-mediated interactions shape affinity and selectivity in the LAO binding protein. FEBS J. 2020;287:763\u2013782. doi: 10.1111/febs.15019.", "ArticleIdList": ["10.1111/febs.15019", "31348608"]}, {"Citation": "Adinortey C.A., Kwarko G.B., Koranteng R., Boison D., Obuaba I., Wilson M.D., Kwofie S.K. Molecular structure-based screening of the constituents of Calotropis procera identifies potential inhibitors of diabetes mellitus target alpha glucosidase. Curr. Issues Mol. Biol. 2022;44:963\u2013987. doi: 10.3390/cimb44020064.", "ArticleIdList": ["10.3390/cimb44020064", "PMC8928985", "35723349"]}, {"Citation": "Tuersuntuoheti T., Pan F., Zhang M., Wang Z., Han J., Sun Z., Song W. Prediction of DPP-IV inhibitory potentials of polyphenols existed in Qingke barley fresh noodles: In vitro and in silico analyses. J. Food Process. Preserv. 2022:e16808. doi: 10.1111/jfpp.16808.", "ArticleIdList": ["10.1111/jfpp.16808"]}, {"Citation": "Chen D., Oezguen N., Urvil P., Ferguson C., Dann S.M., Savidge T.C. Regulation of protein-ligand binding affinity by hydrogen bond pairing. Sci. Adv. 2016;2:e1501240. doi: 10.1126/sciadv.1501240.", "ArticleIdList": ["10.1126/sciadv.1501240", "PMC4820369", "27051863"]}, {"Citation": "Childers M.C., Daggett V. Insights from molecular dynamics simulations for computational protein design. Mol. Syst. Des. Eng. 2017;12:9\u201333. doi: 10.1039/C6ME00083E.", "ArticleIdList": ["10.1039/C6ME00083E", "PMC5321087", "28239489"]}, {"Citation": "Martinez L. Automatic Identification of Mobile and Rigid Substructures in Molecular Dynamics Simulations and Fractional Structural Fluctuation Analysis. PLoS ONE. 2015;10:e0119264. doi: 10.1371/journal.pone.0119264.", "ArticleIdList": ["10.1371/journal.pone.0119264", "PMC4376797", "25816325"]}, {"Citation": "Rosenberg M.S. Sequence Alignment: Methods, Models, Concepts and Strategies. University of California Press; Berkeley, CA, USA: 2009.", "ArticleIdList": ["10.1525/9780520943742"]}, {"Citation": "Nath V., Manish R., Neeraj K., Agrawal R., Kumar V. Computational identification of potential dipeptidyl peptidase (DPP)-IV inhibitors: Structure based virtual screening, molecular dynamics simulation and knowledge-based SAR studies. J. Mole. Struct. 2021;1224:129006. doi: 10.1016/j.molstruc.2020.129006.", "ArticleIdList": ["10.1016/j.molstruc.2020.129006"]}, {"Citation": "Cherrak S.A., Merzouk H., Mokhtari-Soulimane N. Potential bioactive glycosylated flavonoids as SARS-CoV-2 main protease inhibitors: A molecular docking and simulation studies. PLoS ONE. 2020;15:e0240653. doi: 10.1371/journal.pone.0240653.", "ArticleIdList": ["10.1371/journal.pone.0240653", "PMC7561147", "33057452"]}, {"Citation": "Shode F.O., Idowu A.S.K., Uhomoibhi O.J., Sabiu S. Repurposing drugs and identification of inhibitors of integral proteins (spike protein and main protease) of SARS-CoV-2. J. Biomol. Struct. Dyn. 2022;40:6587\u20136602. doi: 10.1080/07391102.2021.1886993.", "ArticleIdList": ["10.1080/07391102.2021.1886993", "PMC7898306", "33590806"]}, {"Citation": "Chen J., Wu S., Zhang Q., Yin Z., Zhang L. \u03b1-Glucosidase inhibitory effect of anthocyanins from Cinnamomum camphora fruit: Inhibition kinetics and mechanistic insights through in vitro and in silico studies. Int. J. Biol. Macromol. 2020;143:696\u2013703. doi: 10.1016/j.ijbiomac.2019.09.091.", "ArticleIdList": ["10.1016/j.ijbiomac.2019.09.091", "31521662"]}, {"Citation": "Khan S., Bjij I., Betz R.M., Soliman M.E. Reversible versus irreversible inhibition modes of ERK2: A comparative analysis for ERK2 protein kinase in cancer therapy. Future Med. Chem. 2018;10:1003\u20131015. doi: 10.4155/fmc-2017-0275.", "ArticleIdList": ["10.4155/fmc-2017-0275", "29629569"]}, {"Citation": "Zhang D., Lazim R. Application of conventional molecular dynamics simulation in evaluating the stability of apomyoglobin in urea solution. Sci. Rep. 2017;7:1\u201312. doi: 10.1038/srep44651.", "ArticleIdList": ["10.1038/srep44651", "PMC5353640", "28300210"]}, {"Citation": "Khan S., Fakhar Z., Hussain A., Ahmad A., Jairajpuri D., Alajmi M., Hassan M. Structure-based identification of potential SARS-CoV-2 main protease inhibitors. J. Biomolec. Struct Dyn. 2020;40:3595\u20133608. doi: 10.1080/07391102.2020.1848634.", "ArticleIdList": ["10.1080/07391102.2020.1848634", "PMC7682383", "33210561"]}, {"Citation": "Khan M.S., Husain F.M., Alhumaydhi F.A., Alwashmi A.S.S., Rehman M.T., Alruwetei A.M., Hassan M.I., Islam A., Shamsi A. Exploring the molecular interactions of Galantamine with human Transferrin: In-silico and in vitro insight. J. Molec. Liq. 2021;335:1\u20139."}, {"Citation": "Hubbard R.E., Haider M.K. Hydrogen Bonds in Proteins: Role and Strength. eLS John Wiley & Sons, Ltd.; Hoboken, NJ, USA: 2010."}, {"Citation": "Alhumaydhi F.A., Aljasir M.A., Abdullah S.M., Aljohani S.A.A., Alwashimi A.S.S., Shahwan M., Hassan M.I., Islam A., Shamsi A. Probing the interaction of memantine, an important Alzheimer\u2019s drug, with human serum albumin: In silico and in vitro approach. J. Molec. Liq. 2021;340:116888. doi: 10.1016/j.molliq.2021.116888.", "ArticleIdList": ["10.1016/j.molliq.2021.116888"]}, {"Citation": "Lipinski C.A., Lombardo F., Dominy B.W., Feeney P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 2001;46:3\u201326. doi: 10.1016/S0169-409X(00)00129-0.", "ArticleIdList": ["10.1016/S0169-409X(00)00129-0", "11259830"]}, {"Citation": "Price G., Patel D.A. Drug Bioavailability. StatPearls Publishing; Treasure Island, FL, USA: 2020.", "ArticleIdList": ["32496732"]}, {"Citation": "Zhou Y., Zhou T., Pei D., Liu S., Yuan H. Pharmacokinetics and tissue distribution study of chlorogenic acid from lonicerae japonicae flos following oral administrations in rats. Evid. Based Complement. Altern. Med. 2014;2014:979414. doi: 10.1155/2014/979414.", "ArticleIdList": ["10.1155/2014/979414", "PMC4130225", "25140190"]}, {"Citation": "Qi W., Zhao T., Yang W., Wang G., Yu H., Zhao H., Yang C., Sun L. Comparative pharmacokinetics of chlorogenic acid after oral administration in rats. J. Pharm. Anal. 2011;1:270\u2013274. doi: 10.1016/j.jpha.2011.09.006.", "ArticleIdList": ["10.1016/j.jpha.2011.09.006", "PMC5760807", "29403709"]}, {"Citation": "Geldenhuys W.J., Mohammad A.S., Adkins C.E., Lockman P.R. Molecular determinants of blood\u2013brain barrier permeation. Ther. Deliv. 2015;6:961\u2013971. doi: 10.4155/tde.15.32.", "ArticleIdList": ["10.4155/tde.15.32", "PMC4675962", "26305616"]}, {"Citation": "Ahern K., Rajagopal I. Enzyme Inhibition.  [(accessed on 10 January 2022)].  Available online:  https://chem.libretexts.org/Courses/University_of_Arkansas_Little_Rock/CHEM_4320_5320%3A_Biochemistry_1/05%3A_MichaelisMenten_Enzyme_Kinetics/5.4%3A_Enzyme_Inhibition."}, {"Citation": "Motoshima K., Sugita K., Hashimoto Y., Ishikawa M. Non-competitive and selective dipeptidyl peptidase IV inhibitors with phenethylphenylphthalimide skeleton derived from thalidomide-related \u03b1-glucosidase inhibitors and liver X receptor antagonists. Bioorg. Med. Chem. Lett. 2011;21:3041\u20133045. doi: 10.1016/j.bmcl.2011.03.026.", "ArticleIdList": ["10.1016/j.bmcl.2011.03.026", "21478015"]}, {"Citation": "Nong N.T.P., Chen Y.-K., Shih W.-L., Hsu J.-L. Characterization of novel dipeptidyl peptidase-IV inhibitory peptides from soft-shelled turtle yolk hydrolysate using orthogonal bioassay-guided fractionations coupled with in vitro and in silico study. Pharmaceuticals. 2020;13:308. doi: 10.3390/ph13100308.", "ArticleIdList": ["10.3390/ph13100308", "PMC7602288", "33066488"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "9", "Day": "20"}, {"Year": "2022", "Month": "9", "Day": "28"}, {"Year": "2022", "Month": "9", "Day": "29"}, {"Year": "2022", "Month": "10", "Day": "27", "Hour": "1", "Minute": "39"}, {"Year": "2022", "Month": "10", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "10", "Day": "28", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "10", "Day": "2"}], "PublicationStatus": "epublish", "ArticleIdList": ["36295839", "PMC9608993", "10.3390/metabo12100937", "metabo12100937"]}}], "PubmedBookArticle": []}